Mokari Atabak
- SEC CIK
- 0001678419
In the past year, 4 open-market sale filings worth $18.7M and no purchases.
Current role at each company
- CORT Corcept Therapeutics IncChief Financial Officeras of Sep 3, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $18.7M
- 4 filings
- Net
- −$18.7M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Mokari Atabak as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 (view filing)4:30 PM ET | Jul 30 | 4 days | Mokari AtabakChief Financial Officer | SSale | −80.0K | $114.71 | −$9.18M | −83.2%16.1K after | 13 lots10b5-1 |
| Jul 17, 2026 (view filing)6:31 PM ET | Jul 15 | 2 days | Mokari AtabakChief Financial Officer | SSale | −40.0K | $87.71 | −$3.51M | −71.3%16.1K after | 4 lots10b5-1 |
| Jun 17, 2026 (view filing) | Jun 15 | 2 days | Mokari AtabakChief Financial Officer | SSale | −40.0K | $81.15 | −$3.25M | −71.3%16.1K after | 4 lots10b5-1 |
| Jun 3, 2026 (view filing) | Jun 1 | 2 days | Mokari AtabakChief Financial Officer | SSale | −40.0K | $70.00 | −$2.80M | −72.4%15.3K after | 10b5-1 |